Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

38 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mapping of Transcription Start Sites of Normal and Cancerous Prostate Cells

ABSTRACT: Capped analysis of gene expression (CAGE) sequencing was done on a normal and a cancer cell line to examine how promoter usage changes between these two states. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

ORGANISM(S): Homo sapiens

SUBMITTER: Aaron Statham

PROVIDER: E-GEOD-38677 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Normal and Cancerous Prostate Cells

Project description:This SuperSeries is composed of the following subset Series: GSE38674: Genomic DNA in Normal and Cancerous Prostate Cells GSE38676: Expression Analysis of Normal and Cancerous Prostate Cells GSE38677: Mapping of Transcription Start Sites of Normal and Cancerous Prostate Cells GSE38682: H3K4me3 Marks in Normal and Cancerous Prostate Cells GSE38683: H3K27me3 Marks in Normal and Cancerous Prostate Cells GSE38684: Chromatin Looping of Normal and Cancerous Prostate Cells Refer to individual Series

2012-10-16 | E-GEOD-38685 | biostudies-arrayexpress

Genomic DNA in Normal and Cancerous Prostate Cells

Project description:To investiagate copy number differences between PrEC and LNCaP cells, each was DNA sequenced. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38674 | biostudies-arrayexpress

H3K27me3 Marks in Normal and Cancerous Prostate Cells

Project description:The histone modification H3K27me3 is representative of silenced regions of the genome. Changes between the normal and cancer state were investigated. Three PrEC samples, a normal cell line. Four LNCaP sample, a cancer cell line. Technical replicates.

2012-11-30 | E-GEOD-38683 | biostudies-arrayexpress

Chromatin Looping of Normal and Cancerous Prostate Cells

Project description:Mapping the locations of the DNA binding protein CTCF genome-wide to assess its colocalisation with expression domain boundaries. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38684 | biostudies-arrayexpress

H3K4me3 Marks in Normal and Cancerous Prostate Cells

Project description:H3K4me3 ChIP-seq was done to examine transcription start sites in a genome wide manner, and compare results to CAGE-seq One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38682 | biostudies-arrayexpress

Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations [RNA-seq]

Project description:Nonsense-mediated mRNA decay (NMD) surveillance pathways are best known to be involved in the degradation of mRNA with premature termination codons (PTCs). More recent studies demonstrate that the role of NMD pathways goes well beyond the degradation of PTC containing mRNA, into the regulation of cell function and thus normal development. We have taken advantage of the availability of naturally occurring loss of function mutations in the UPF3B gene, a major component of the exon junction complex (EJC), to inquire about genome-wide consequences of compromised NMD. We identify that about 5% of the lymphoblastoid cell transcriptome is directly or indirectly impacted upon in patients with UPF3B mutations with minimal effect on alternative splicing. We identify UPF3A-NMD as a likely, major modifier of the UPF3B patient phenotype through variable UPF3A protein stabilisation. Among the most consistently deregulated direct targets of UPF3B-NMD we identify the ARHGAP24 as the most likely gene implicated in the neuronal phenotype of UPF3B patients. To assess the impact of UPF3B-NMD deficiency on human transcriptome, we sequenced polyA RNA extracted from lymphoblastoid cell lines of patients (n=4) and controls (n=2). We complemented the analysis using Affymetrix Human Exon 1.0 St array using total RNA of the same cell line from patients (n=5, 3 of whom were also sequenced) and controls (n=5). Moreover, we overlapped identified differently expressed genes with copy number variation data of the patients, obtained using Illumina Human Omniexpress chip, to exclude possible false positive. Supplementary file: A splice junction reference file generated for alignment of junction reads. Alignment files linked to individual Sample records.

2011-11-01 | E-GEOD-27199 | biostudies-arrayexpress

DNA Methylation in IMR90 cells

Project description:DNA methylation was measured by MBD2 enrichment of DNA fragments in IMR90. A statistical model was developed to estimate absolute methylation levels, and compared to whole genome bisulfite sequencing results (Lister, R. et al. (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature) Two techincal replicates of MBD2 methylated DNA enrichment in IMR90 cells.

2012-11-30 | E-GEOD-38679 | biostudies-arrayexpress

Expression Analysis of Normal and Cancerous Prostate Cells

Project description:Strand-specific RNA sequencing was done on a normal and a cancer cell line to examine how isoforms are used differently between these two states. One PrEC sample, a normal cell line. One LNCaP sample, a cancer cell line.

2012-11-30 | E-GEOD-38676 | biostudies-arrayexpress

Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations [mRNA profiling]

2011-11-01 | E-GEOD-27125 | biostudies-arrayexpress

Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations

Project description:This SuperSeries is composed of the following subset Series: GSE27125: Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations [mRNA profiling] GSE27199: Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations [RNA-seq] GSE27412: Genome-wide consequences of compromised NMD and their relavence for variable clinical phenotype of patients with UPF3B mutations [CNV] Refer to individual Series

2011-11-01 | E-GEOD-27433 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data